Showing results (241-250 of 691) with videos related to
Sort By:
Pageof 70
Neuro-Oncology|February 11, 2005
Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case studyJohn H Sampson, David A Reardon, Allan H Friedman, et al.Leukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasivenessDieter Lemke, Philipp-Niclas Pfenning, Felix Sahm, et al.Frontiers in Immunology|June 2, 2020
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβTakumi Kudo, Mirja T Prentzell, Soumya R Mohapatra, et al.Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.Journal of Neuroimmunology|July 12, 2016
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammationMelanie Keil, Jana K Sonner, Tobias V Lanz, et al.Plos One|October 19, 2012
Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseMartina Ott, Ulrike M Litzenburger, Felix Sahm, et al.Journal of Neuro-Oncology|November 29, 2019
cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastomaAnne Berberich, Lara-Marie Schmitt, Stefan Pusch, et al.Biochemical Pharmacology|September 6, 2015
Toxicity of teriflunomide in aryl hydrocarbon receptor deficient miceChiara Redaelli, Ece Cazibe Gaffarogullari, Maik Brune, et al.Journal of Neuro-Oncology|April 17, 2019
Survival and prognostic factors in surgically treated brain metastasesVasileios K Kavouridis, Maya Harary, Alexander F C Hulsbergen, et al.Pageof 70